Search research articles
Contact Us
Filters
Showing results (221-230 of 418) with videos related to
Page
of 42
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
Andres F Correa, Opeyemi Jegede, Naomi B Haas, et al.
The Lancet. Oncology
|
February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
Mahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
Cancer
|
October 11, 2013
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer
Christine A Ciunci, Rodolfo F Perini, Anjali N Avadhani, et al.
The Lancet. Oncology
|
February 4, 2014
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials
Keith T Flaherty, Michael Hennig, Sandra J Lee, et al.
Cancer Immunology Research
|
June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade
Zachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Nature Medicine
|
September 18, 2012
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
Lawrence N Kwong, James C Costello, Huiyun Liu, et al.
Plos One
|
July 1, 2024
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies
Shiyou Wei, Kuang Du, Hongbin Lan, et al.
Cancer Research
|
May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human Cancer
Dongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Page
of 42
Search research articles
Search
Showing results (221-230 of 418) with videos related to
Sort By:
Page
of 42
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
Andres F Correa, Opeyemi Jegede, Naomi B Haas, et al.
The Lancet. Oncology
|
February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
Mahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
Cancer
|
October 11, 2013
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer
Christine A Ciunci, Rodolfo F Perini, Anjali N Avadhani, et al.
The Lancet. Oncology
|
February 4, 2014
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials
Keith T Flaherty, Michael Hennig, Sandra J Lee, et al.
Cancer Immunology Research
|
June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade
Zachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Nature Medicine
|
September 18, 2012
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
Lawrence N Kwong, James C Costello, Huiyun Liu, et al.
Plos One
|
July 1, 2024
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies
Shiyou Wei, Kuang Du, Hongbin Lan, et al.
Cancer Research
|
May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human Cancer
Dongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Page
of 42